Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "High Potency API Contract Manufacturing Market by Product, Synthesis, Application, Dosage Form, End User and Region" report has been added to ...
AUSTIN, Texas and TOKYO, Oct. 3, 2025 /PRNewswire/ -- According to DataM Intelligence, the Active Pharmaceutical Ingredients Market Size reached US$ 238.7 Billion in 2024, up from US$ 224.7 Billion in ...
The Active Pharmaceutical Ingredient (API) Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As industries ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
BEDMINSTER, N.J. and DUBLIN, Ireland, Aug 26, 2013 (GLOBE NEWSWIRE via COMTEX) -- Amarin Corporation plc AMRN +4.29% , a biopharmaceutical company focused on the commercialization and development of ...
Aoxing Pharmaceutical (NYSE Amex: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, ...
MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients. Following the MHRA decision, pharma& expects that ...
Shardul Nautiyal, Mumbai Friday, January 2, 2026, 08:00 Hrs [IST] ...
The latest report published by Report Ocean, titled “Europe Active Pharmaceutical Ingredients (API) Market“: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024 to 2034,” offers a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback